A retrospective, observational study analysing efficacy and safety of Brentuximab Vedotin plus Cyclophosphamide, Epirubicin and Prednisone in untreated lymphoma
Latest Information Update: 26 Nov 2021
At a glance
- Drugs Brentuximab vedotin (Primary) ; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Prednisone; Vincristine
- Indications Anaplastic large cell lymphoma; Extranodal NK-T-cell lymphoma; Follicular lymphoma; Mycosis fungoides; Peripheral T-cell lymphoma; T-cell lymphoma
- Focus Therapeutic Use
- 26 Nov 2021 New trial record
- 19 Nov 2021 Results published in the Advances in Therapy